PharmaLex corrects serious non-compliance issue and protects millions of £s of annual sales for product range

  • PharmaLex were given the responsibility of providing regulatory services to a pharmaceutical company who had acquired two licensed medicines in a range of formulations and strengths from big pharma. These originator products had EU sales in the millions and PharmaLex were engaged to provide regulatory support to all the client’s local EU affiliate offices.